Results 11 to 20 of about 406,493 (428)
Comparing results of bypass surgery and percutaneous coronary intervention for left main disease by surgical revascularization pump strategy [PDF]
Objective: We performed a post hoc analysis of the Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial to determine the effect an on-versus off-pump strategy had on outcomes when ...
Abu-Omar, Yasir+12 more
core +1 more source
Antiplatelet therapy after percutaneous coronary intervention.
Antiplatelet therapy is key to reducing local thrombotic complications and systemic ischaemic events among patients undergoing percutaneous coronary interventions (PCI), but it is inevitably associated with increased bleeding.
D. Angiolillo+4 more
semanticscholar +1 more source
Racial/Ethnic Differences Persist in Treatment Choice and Outcomes in Isolated Intervention for Coronary Artery Disease [PDF]
OBJECTIVE: Studies have noted racial/ethnic disparities in coronary artery disease intervention strategies. We investigated trends and outcomes of coronary artery disease treatment choice (coronary artery bypass grafting or percutaneous coronary ...
Asokan, Sainath+10 more
core +2 more sources
As the incidence of coronary heart disease increases annually, coronary angiography and percutaneous coronary intervention procedures are also increasing. The femoral artery and radial artery paths are commonly used for percutaneous coronary intervention,
Gang Cao, Hua-xiu Cai, Jun Cao
doaj +1 more source
Imaging in Percutaneous Coronary Intervention
Intracoronary imaging (ICI) use during percutaneous coronary intervention (PCI) has been shown to effectively improve cardiovascular outcomes, particularly for high-risk subgroups. However, data from randomized controlled trials are limited and the overall utilization rate of ICI remains variable between different countries and centers.
Mohan Satish+10 more
openaire +3 more sources
A growing number of patients undergoing percutaneous coronary intervention (PCI) with stent implantation also have atrial fibrillation. This poses challenges for their optimal antithrombotic management because patients with atrial fibrillation undergoing
D. Angiolillo+14 more
semanticscholar +1 more source
The main finding in our study is that Clinical Frailty Scale‐defined frailty status was predictive of 1‐year post‐interventional mortality after left ventricular assist device implantation. Abstract Objectives Heart failure impacts patients’ functional capabilities, ultimately leading to frailty.
Temitope Ajibawo+3 more
wiley +1 more source
Bivalirudin in percutaneous coronary intervention [PDF]
Bivalirudin is a member of the direct thrombin inhibitor group of anticoagulants. It has been evaluated as an alternative to unfractionated and low-molecular-weight heparins in the settings of percutaneous coronary intervention (PCI) and acute coronary syndrome (ACS). Results of clinical trials to date suggest bivalirudin is a viable alternative to the
Lehman, Sam, Chew, Derek Peng
openaire +4 more sources
Guidelines for Percutaneous Coronary Interventions [PDF]
In patients with stable CAD, PCI can be considered a valuable initial mode of revascularization in all patients with objective large ischaemia in the presence of almost every lesion subset, with only one exception: chronic total occlusions that cannot be crossed. In early studies, there was a small survival advantage with CABG surgery compared with PCI
Silber, Sigmund+29 more
openaire +5 more sources
Background Patients who experience angina and acute myocardial infarction often receive diagnostic coronary angiography and percutaneous coronary intervention.
Ali Asghar Farsavian+3 more
doaj +1 more source